Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 158.0 | 49 | |
| RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 165.0 | 62 | |
| RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 125.5 | 50 | |
| RA2159 | EO1428 | 1.0 | uM | 3 | IL-15 | 105.5 | 70 | ||||
| N2586 | TNF-a | 100 | ng/mL | 3 | IL-15 | 139.0 | 69 | ||||
| N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 161.0 | 53 | |
| N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 160.5 | 68 | |
| N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 90.0 | 41 | |
| N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 106.0 | 45 | |
| N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-15 | 137.5 | 70 | |
| N2586 | EO1428 | 1.0 | uM | 3 | IL-15 | 98.0 | 53 | ||||
| 0 | IL-15 | 113.0 | 41 | ||||||||
| RA2159 | 3 | IL-15 | 98.0 | 49 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 3 | IL-15 | 181.0 | 68 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-15 | 102.0 | 64 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-15 | 140.5 | 68 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 113.0 | 40 | ||||
| RA2159 | IKK16 | 2.0 | uM | 3 | IL-15 | 108.0 | 51 | ||||
| RA2159 | 3 | IL-15 | 89.5 | 56 | |||||||
| N2586 | 3 | IL-15 | 111.0 | 59 | |||||||
| N2586 | PD184352 | 0.1 | uM | 3 | IL-15 | 106.0 | 65 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 3 | IL-15 | 100.5 | 50 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 3 | IL-15 | 104.0 | 41 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | IL-15 | 105.0 | 31 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | IL-15 | 101.5 | 60 |